Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added the principal investigator, Lauren Carcas, MD, and contact email; expanded recruitment sites to Kendall and Plantation, FL (Miami Cancer Institute at Baptist Health), bringing total locations to 14, and updated the Last Update Posted (Estimated) to 2025-12-03.
    Difference
    1%
    Check dated 2025-12-10T02:08:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications are now described as automatically filled from PubMed and the page records Revision: v3.3.2, replacing the previous wording tied to PubMed-derived entries and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page no longer displays the general government funding status notice, a site-wide banner not specific to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:32:18.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No significant changes detected; minor wording and formatting adjustments across the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:06:53.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Added a prominent operations/uptime notice and current status guidance, including a link to cc.nih.gov and opm.gov. - Updated the version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:25:31.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    - Updated page revision to v3.1.0 and added multiple contact emails. - Removed reference to the older revision v3.0.2. No other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T05:10:41.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.